Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle
Completed · Phase 4
Conditions studied: Influenza, Respiratory Viral Infection
In brief
This study will evaluate a home-based approach to influenza infection control, using prepositioned home-based influenza self-test kits, telemedicine services, and rapid delivery of Xofluza (Baloxavir marboxil) for administration within 48 hours of symptom onset.
Key facts
- Study ID
- NCT04141930
- Run by
- University of Washington
- People needed
- 481
- Starts
- 2019-11-01
- Expected to finish
- 2020-04-01
- Last updated by the study team
- 2021-08-05
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Household Level:
- Group of at least 3 individuals of any ages defined as at least 3 persons residing at the same address for at least 4 days per calendar week
- Household group utilizes common household areas
- At least 2 household members meeting all individual inclusion/exclusion criteria listed below and willing to participate (e.g. at least two members of the household are 12 years of age or older)
- At least one member of the household has a smartphone
- Individual Level: Drug Eligible
- Resident of a household with 3 or more members (including eligible cases) for 4 or more days a calendar week
- Age 12 years or older weighing at least 40 kg (greater than 88 pounds)
- Willing and able to take study medication
- Willing to comply with all study procedures
- English-speaking
- Able to provide written, informed consent and/or assent (if applicable)
- Permanent mailing address that is available for study staff to mail necessary materials
- Individual Level: Drug Ineligible
- Resident of a household with 3 or more members (including eligible cases) for 4 or more days a calendar week
- Willing to comply with all study procedures
- English-speaking
- Able to provide written, informed consent and/or assent (if applicable)
You may not qualify if…
- Household Level:
- Previous documentation of an influenza infection prior to or during the annual influenza season in any household member prior to enrollment
- Individual Level:
- Any serious or uncontrolled medical disorder or active infection that, in the opinion of the investigator, may increase the risk associated with study participation or study drug administration
- Individuals with hypersensitivity to baloxavir
- Individuals that already have a tele-health account
- Any individual that has one or more of the following conditions:
- Pregnant
- Currently lactating
- Immunosuppressed or immunocompromised (by disease or medication)
- Cancer
- Liver disease
- Kidney disease
Where it is running
- University of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.